Jing Xu

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes

K. Martin Kortüm, Nur Hafzan Md Hanafiah, Chang-Xi Shi et al. · Blood · 2016 · 256 citations · Full text

Medicine, Molecular Genetics, Oncology +14

LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling

Qiurong Yang, Maoye Wang, Jing Xu et al. · Molecular Cancer · 2023 · 91 citations · Full text

Medicine, Molecular Biology, Oncology +17

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation

Jing Xu, Nicole Pfarr, Volker Endris et al. · Oncogenesis · 2017 · 89 citations · Full text

Medicine, Cancer Biology, Oncology +17

Analyses of rare predisposing variants of lung cancer in 6,004 whole genomes in Chinese

Cheng Wang, Juncheng Dai, Na Qin et al. · Cancer Cell · 2022 · 68 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease

George J. Kahaly, Peter J. Dolman, Jan Wolf et al. · The Journal of Clinical Endocrinology & Metabolism · 2023 · 61 citations · Full text

Medicine, Endocrinology, Pharmacology +15